➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Moodys
McKinsey
Harvard Business School
Johnson and Johnson

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Investigational Drugs with Clinical Trials for: Renal Insufficiency, Chronic


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drugname Indication
T-62 Renal Insufficiency, Chronic
ASP1517 Renal Insufficiency, Chronic
Thymalfasin Renal Insufficiency, Chronic
TAK-438 Renal Insufficiency, Chronic
TAK-475 Renal Insufficiency, Chronic
Fasiglifam Renal Insufficiency, Chronic
Atrasentan Renal Insufficiency, Chronic
>Drugname >Indication

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Mallinckrodt
McKinsey
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.